• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种疫苗者与自然感染者中SARS-CoV-2刺突蛋白T细胞表位的差异反应性。

Differential reactivity of SARS-CoV-2 S-protein T-cell epitopes in vaccinated versus naturally infected individuals.

作者信息

Browne Daniel J, Crooks Pauline, Smith Corey, Doolan Denise L

机构信息

Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine James Cook University Cairns QLD Australia.

QIMR Berghofer Centre for Immunotherapy and Vaccine Development and Translational and Human Immunology Laboratory, Department of Immunology QIMR Berghofer Medical Research Institute Brisbane QLD Australia.

出版信息

Clin Transl Immunology. 2025 May 6;14(5):e70031. doi: 10.1002/cti2.70031. eCollection 2025 May.

DOI:10.1002/cti2.70031
PMID:40342296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12056234/
Abstract

OBJECTIVES

Vaccine-induced protective immunity against SARS-CoV-2 has proved difficult to sustain. Robust T-cell responses are thought to play an important role, but T-cell responses against the SARS-CoV-2 spike protein (S-protein), the core vaccine antigen, following vaccination or natural infection are incompletely understood.

METHODS

Herein, the reactivity of 170 putative SARS-CoV-2 S-protein CD8 and CD4 T-cell peptide epitopes in the same individuals prior to vaccination, after COVID-19 vaccination, and again following subsequent natural infection was assayed using a high-throughput reverse transcription-quantitative PCR (HTS-RT-qPCR) assay.

RESULTS

The profile of immunoreactive SARS-CoV-2 S-protein epitopes differed between vaccination and natural infection. Vaccine-induced immunoreactive epitopes were localised primarily into two extra-domanial regions. In contrast, epitopes recognised following natural infection were spread across the antigen. Furthermore, T-cell epitopes in naïve individuals were primarily recognised in association with HLA-A, while natural infection shifted epitope associations towards HLA-B, particularly the B7 supertype.

CONCLUSION

This study provides insight into T-cell responses against the SARS-CoV-2 S-protein following vaccination and subsequent natural infection.

摘要

目的

事实证明,疫苗诱导的针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的保护性免疫难以持久。强大的T细胞反应被认为起着重要作用,但对于接种疫苗或自然感染后针对核心疫苗抗原SARS-CoV-2刺突蛋白(S蛋白)的T细胞反应,人们尚未完全了解。

方法

在此,使用高通量逆转录定量聚合酶链反应(HTS-RT-qPCR)检测法,对170个假定的SARS-CoV-2 S蛋白CD8和CD4 T细胞肽表位在同一人群接种疫苗前、接种2019冠状病毒病(COVID-19)疫苗后以及随后再次自然感染后的反应性进行了检测。

结果

接种疫苗和自然感染后,免疫反应性SARS-CoV-2 S蛋白表位的情况有所不同。疫苗诱导的免疫反应性表位主要定位于两个域外区域。相比之下,自然感染后识别的表位分布在整个抗原上。此外,未接触过抗原的个体中的T细胞表位主要与HLA-A相关,而自然感染使表位关联转向HLA-B,尤其是B7超型。

结论

本研究深入了解了接种疫苗及随后自然感染后针对SARS-CoV-2 S蛋白的T细胞反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3568/12056234/26b8b7bbd160/CTI2-14-e70031-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3568/12056234/57c4951c2a49/CTI2-14-e70031-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3568/12056234/26b8b7bbd160/CTI2-14-e70031-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3568/12056234/57c4951c2a49/CTI2-14-e70031-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3568/12056234/26b8b7bbd160/CTI2-14-e70031-g002.jpg

相似文献

1
Differential reactivity of SARS-CoV-2 S-protein T-cell epitopes in vaccinated versus naturally infected individuals.接种疫苗者与自然感染者中SARS-CoV-2刺突蛋白T细胞表位的差异反应性。
Clin Transl Immunology. 2025 May 6;14(5):e70031. doi: 10.1002/cti2.70031. eCollection 2025 May.
2
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
3
Ad5-nCoV Vaccination Could Induce HLA-E Restricted CD8 T Cell Responses Specific for Epitopes on Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein.Ad5-nCoV 疫苗接种可诱导针对严重急性呼吸综合征冠状病毒 2 刺突蛋白表位的 HLA-E 限制性 CD8 T 细胞反应。
Viruses. 2023 Dec 28;16(1):52. doi: 10.3390/v16010052.
4
Characterizing HLA-A2-restricted CD8 T-cell epitopes and immune responses to Omicron variants in SARS-CoV-2-inactivated vaccine recipients.鉴定新冠病毒灭活疫苗接种者中HLA-A2限制性CD8 T细胞表位及对奥密克戎变异株的免疫反应
Front Immunol. 2025 Mar 18;16:1534530. doi: 10.3389/fimmu.2025.1534530. eCollection 2025.
5
COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.基于全球人群中 HLA Ⅰ类基因座(HLA-A、-B、-C)分布的 COVID-19 冠状病毒疫苗 T 细胞表位预测分析。
Hum Vaccin Immunother. 2021 Apr 3;17(4):1097-1108. doi: 10.1080/21645515.2020.1823777. Epub 2020 Nov 11.
6
Landscape and selection of vaccine epitopes in SARS-CoV-2.SARS-CoV-2 疫苗表位的景观和选择。
Genome Med. 2021 Jun 14;13(1):101. doi: 10.1186/s13073-021-00910-1.
7
SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.在 COVID-19 康复者中鉴定出的 SARS-CoV-2 特异性记忆 T 细胞表位。
Virus Res. 2021 Oct 15;304:198508. doi: 10.1016/j.virusres.2021.198508. Epub 2021 Jul 27.
8
mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.mRNA 疫苗诱导的 T 细胞对 SARS-CoV-2 关切变异株的反应完全相同,但根据先前的感染状态,其持久性和归巢特性存在差异。
Elife. 2021 Oct 12;10:e72619. doi: 10.7554/eLife.72619.
9
Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.针对 SARS-CoV-2 的合成肽疫苗的临床前评估,该疫苗可诱导多表位和交叉反应性体液中和以及细胞 CD4 和 CD8 反应。
Emerg Microbes Infect. 2021 Dec;10(1):1931-1946. doi: 10.1080/22221751.2021.1978823.
10
Cellular interferon-gamma and interleukin-2 responses to SARS-CoV-2 structural proteins are broader and higher in those vaccinated after SARS-CoV-2 infection compared to vaccinees without prior SARS-CoV-2 infection.与未感染过 SARS-CoV-2 的疫苗接种者相比,SARS-CoV-2 感染后接种疫苗的个体对 SARS-CoV-2 结构蛋白的细胞干扰素-γ和白细胞介素-2 反应更广泛且更高。
PLoS One. 2022 Oct 17;17(10):e0276241. doi: 10.1371/journal.pone.0276241. eCollection 2022.

本文引用的文献

1
Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer.癌症成年患者对新冠疫苗接种的全面体液免疫和细胞免疫反应。
Vaccine. 2025 Feb 6;46:126547. doi: 10.1016/j.vaccine.2024.126547. Epub 2024 Dec 7.
2
Technical pitfalls when collecting, cryopreserving, thawing, and stimulating human T-cells.收集、冷冻保存、解冻和刺激人 T 细胞时的技术陷阱。
Front Immunol. 2024 May 15;15:1382192. doi: 10.3389/fimmu.2024.1382192. eCollection 2024.
3
Studying antigen-specific T cells through a streamlined, whole blood-based extracellular approach.
通过简化的、基于全血的细胞外方法研究抗原特异性 T 细胞。
Cytometry A. 2024 Apr;105(4):288-296. doi: 10.1002/cyto.a.24818. Epub 2023 Dec 27.
4
HLA-DQ2/8 and COVID-19 in Celiac Disease: Boon or Bane.乳糜泻中的HLA - DQ2/8与新冠病毒感染:福还是祸。
Microorganisms. 2023 Dec 13;11(12):2977. doi: 10.3390/microorganisms11122977.
5
Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case-control study.BNT162b2 BA.4/5 二价 mRNA 疫苗在美国大型医疗体系中针对一系列 COVID-19 结局的有效性:一项病例对照研究。
Lancet Respir Med. 2023 Dec;11(12):1089-1100. doi: 10.1016/S2213-2600(23)00306-5. Epub 2023 Oct 25.
6
SARS-CoV-2 evolution in the Omicron era.奥密克戎时代的 SARS-CoV-2 进化。
Nat Microbiol. 2023 Nov;8(11):1952-1959. doi: 10.1038/s41564-023-01504-w. Epub 2023 Oct 16.
7
A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection.常见的 HLA 等位基因与无症状 SARS-CoV-2 感染相关。
Nature. 2023 Aug;620(7972):128-136. doi: 10.1038/s41586-023-06331-x. Epub 2023 Jul 19.
8
Insufficient epitope-specific T cell clones are responsible for impaired cellular immunity to inactivated SARS-CoV-2 vaccine in older adults.老年人对灭活 SARS-CoV-2 疫苗的细胞免疫受损,原因是缺乏针对表位的 T 细胞克隆。
Nat Aging. 2023 Apr;3(4):418-435. doi: 10.1038/s43587-023-00379-0. Epub 2023 Mar 13.
9
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study.二价 mRNA 疫苗加强针预防 COVID-19 重症结局的有效性:一项回顾性队列研究。
Lancet Infect Dis. 2023 Aug;23(8):914-921. doi: 10.1016/S1473-3099(23)00122-6. Epub 2023 Apr 14.
10
Correlation of Lymphocyte Subpopulations, Clinical Features and Inflammatory Markers during Severe COVID-19 Onset.重症 COVID-19 发病期间淋巴细胞亚群、临床特征与炎症标志物的相关性
Pathogens. 2023 Mar 6;12(3):414. doi: 10.3390/pathogens12030414.